glp-1 alternative for weight loss As an to injections, a pill has now been approved management ColonBroom GLP-1 Weight Management Supplement

But a newer drug called retatrutide is generating real excitement in the medical community, and for good reason

Universitt Tbingen

Phase 3 Update: TRIUMPH-4 Results Preliminary data from the ongoing Phase 3 TRIUMPH-4 trial (68 weeks) shows higher numbers than Phase 2: 12mg dose: 28.7% average weight loss (~71 lbs / 32 kg) 9mg dose: 26.4% average weight loss (~64 lbs / 29 kg) Knee osteoarthritis pain: 76% reduction (significant quality-of-life improvement) Blood pressure: Average reduction of 14 mmHg Full Phase 3 results across the TRIUMPH program (obesity, diabetes, cardiovascular outcomes, kidney outcomes) are expected throughout 2026

Semaglutide belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which mimic the action of the naturally occurring hormone GLP-1 produced in the intestines

This does not constitute medical advice

Renal impairment or severe gastrointestinal disease: Requires specialist supervision and careful monitoring